Umbilical cord blood DNA methylation in children who later develop type 1 diabetes

Diabetologia. 2022 Sep;65(9):1534-1540. doi: 10.1007/s00125-022-05726-1. Epub 2022 Jun 18.

Abstract

Aims/hypothesis: Distinct DNA methylation patterns have recently been observed to precede type 1 diabetes in whole blood collected from young children. Our aim was to determine whether perinatal DNA methylation is associated with later progression to type 1 diabetes.

Methods: Reduced representation bisulphite sequencing (RRBS) analysis was performed on umbilical cord blood samples collected within the Finnish Type 1 Diabetes Prediction and Prevention (DIPP) Study. Children later diagnosed with type 1 diabetes and/or who tested positive for multiple islet autoantibodies (n = 43) were compared with control individuals (n = 79) who remained autoantibody-negative throughout the DIPP follow-up until 15 years of age. Potential confounding factors related to the pregnancy and the mother were included in the analysis.

Results: No differences in the umbilical cord blood methylation patterns were observed between the cases and controls at a false discovery rate <0.05.

Conclusions/interpretation: Based on our results, differences between children who progress to type 1 diabetes and those who remain healthy throughout childhood are not yet present in the perinatal DNA methylome. However, we cannot exclude the possibility that such differences would be found in a larger dataset.

Keywords: Bisulphite sequencing; DNA methylation; Epigenomics; Follow-up study; Type 1 diabetes; Umbilical cord blood.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Autoantibodies
  • Child
  • Child, Preschool
  • DNA Methylation / genetics
  • Diabetes Mellitus, Type 1*
  • Female
  • Fetal Blood / metabolism
  • Glutamate Decarboxylase
  • Humans
  • Pregnancy

Substances

  • Autoantibodies
  • Glutamate Decarboxylase